vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.
PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $208.9M, roughly 1.0× iRhythm Holdings, Inc.). PHOTRONICS INC runs the higher net margin — 10.9% vs 2.7%, a 8.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -5.5%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -3.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
IRTC vs PLAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $210.4M |
| Net Profit | $5.6M | $22.9M |
| Gross Margin | 70.9% | 33.7% |
| Operating Margin | 1.1% | 22.9% |
| Net Margin | 2.7% | 10.9% |
| Revenue YoY | 27.1% | -5.5% |
| Net Profit YoY | 518.5% | -32.4% |
| EPS (diluted) | $0.18 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | — | ||
| Q3 25 | $192.9M | $210.4M | ||
| Q2 25 | $186.7M | $211.0M | ||
| Q1 25 | $158.7M | $212.1M | ||
| Q4 24 | $164.3M | $222.6M | ||
| Q3 24 | $147.5M | $211.0M | ||
| Q2 24 | $148.0M | $217.0M | ||
| Q1 24 | $131.9M | $216.3M |
| Q4 25 | $5.6M | — | ||
| Q3 25 | $-5.2M | $22.9M | ||
| Q2 25 | $-14.2M | $8.9M | ||
| Q1 25 | $-30.7M | $42.9M | ||
| Q4 24 | $-1.3M | $33.9M | ||
| Q3 24 | $-46.2M | $34.4M | ||
| Q2 24 | $-20.1M | $36.3M | ||
| Q1 24 | $-45.7M | $26.2M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | 33.7% | ||
| Q2 25 | 71.2% | 36.9% | ||
| Q1 25 | 68.8% | 35.6% | ||
| Q4 24 | 70.0% | 37.0% | ||
| Q3 24 | 68.8% | 35.6% | ||
| Q2 24 | 69.9% | 36.5% | ||
| Q1 24 | 66.3% | 36.6% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | -4.4% | 22.9% | ||
| Q2 25 | -10.0% | 26.4% | ||
| Q1 25 | -20.5% | 24.6% | ||
| Q4 24 | -2.5% | 25.1% | ||
| Q3 24 | -34.1% | 24.7% | ||
| Q2 24 | -15.5% | 25.8% | ||
| Q1 24 | -28.9% | 26.6% |
| Q4 25 | 2.7% | — | ||
| Q3 25 | -2.7% | 10.9% | ||
| Q2 25 | -7.6% | 4.2% | ||
| Q1 25 | -19.3% | 20.2% | ||
| Q4 24 | -0.8% | 15.2% | ||
| Q3 24 | -31.3% | 16.3% | ||
| Q2 24 | -13.6% | 16.7% | ||
| Q1 24 | -34.6% | 12.1% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | $0.39 | ||
| Q2 25 | $-0.44 | $0.15 | ||
| Q1 25 | $-0.97 | $0.68 | ||
| Q4 24 | $-0.03 | $0.54 | ||
| Q3 24 | $-1.48 | $0.55 | ||
| Q2 24 | $-0.65 | $0.58 | ||
| Q1 24 | $-1.47 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $575.8M |
| Total DebtLower is stronger | — | $16.0K |
| Stockholders' EquityBook value | $152.7M | $1.1B |
| Total Assets | $1.0B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | — | ||
| Q3 25 | $565.2M | $575.8M | ||
| Q2 25 | $545.5M | $558.4M | ||
| Q1 25 | $520.6M | $642.2M | ||
| Q4 24 | $535.6M | $640.7M | ||
| Q3 24 | $522.0M | $606.4M | ||
| Q2 24 | $561.5M | $559.9M | ||
| Q1 24 | $569.1M | $521.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $16.0K | ||
| Q2 25 | — | $19.0K | ||
| Q1 25 | — | $21.0K | ||
| Q4 24 | — | $25.0K | ||
| Q3 24 | — | $28.0K | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.7M |
| Q4 25 | $152.7M | — | ||
| Q3 25 | $121.9M | $1.1B | ||
| Q2 25 | $103.7M | $1.1B | ||
| Q1 25 | $86.7M | $1.1B | ||
| Q4 24 | $90.9M | $1.1B | ||
| Q3 24 | $71.8M | $1.1B | ||
| Q2 24 | $99.2M | $1.0B | ||
| Q1 24 | $90.3M | $1.0B |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $995.2M | $1.8B | ||
| Q2 25 | $964.0M | $1.7B | ||
| Q1 25 | $926.1M | $1.7B | ||
| Q4 24 | $931.4M | $1.7B | ||
| Q3 24 | $909.7M | $1.6B | ||
| Q2 24 | $919.2M | $1.6B | ||
| Q1 24 | $909.8M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $50.1M |
| Free Cash FlowOCF − Capex | $14.5M | $25.2M |
| FCF MarginFCF / Revenue | 6.9% | 12.0% |
| Capex IntensityCapex / Revenue | 5.6% | 11.8% |
| Cash ConversionOCF / Net Profit | 4.70× | 2.19× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $64.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | — | ||
| Q3 25 | $34.9M | $50.1M | ||
| Q2 25 | $27.7M | $31.5M | ||
| Q1 25 | $-7.9M | $78.5M | ||
| Q4 24 | $19.2M | $68.4M | ||
| Q3 24 | $24.3M | $75.1M | ||
| Q2 24 | $11.8M | $76.5M | ||
| Q1 24 | $-52.0M | $41.5M |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | $25.2M | ||
| Q2 25 | $17.3M | $-29.1M | ||
| Q1 25 | $-17.3M | $43.3M | ||
| Q4 24 | $12.4M | $25.2M | ||
| Q3 24 | $15.5M | $50.7M | ||
| Q2 24 | $3.4M | $56.5M | ||
| Q1 24 | $-61.8M | $-1.8M |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | 12.0% | ||
| Q2 25 | 9.3% | -13.8% | ||
| Q1 25 | -10.9% | 20.4% | ||
| Q4 24 | 7.5% | 11.3% | ||
| Q3 24 | 10.5% | 24.0% | ||
| Q2 24 | 2.3% | 26.0% | ||
| Q1 24 | -46.8% | -0.8% |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 7.7% | 11.8% | ||
| Q2 25 | 5.6% | 28.7% | ||
| Q1 25 | 5.9% | 16.6% | ||
| Q4 24 | 4.2% | 19.4% | ||
| Q3 24 | 6.0% | 11.6% | ||
| Q2 24 | 5.7% | 9.2% | ||
| Q1 24 | 7.4% | 20.0% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | 2.19× | ||
| Q2 25 | — | 3.55× | ||
| Q1 25 | — | 1.83× | ||
| Q4 24 | — | 2.02× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | — | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
